Loading your page…

Pharmaceutical group

Italfarmaco

119 medicines5 countries

A group of 3 companies with 119 medicines in 5 countries.

Its medicines

Group structure

3 companies in 2 countries

Spain2

Italy1

Italfarmaco S.P.A.Authorisation holder · 42 medicines

Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.

Medicines

Every medicine of every company in the group, current ones first.

1–25 of 119

Medicine	Substance	Country	Status	Authorised
ACFOL 5 mg COMPRIMIDOS5 mg · Comprimido	Folic acid	Spain	Marketed	1948
AKELYASospensione orale	Quetiapine	Italy	Authorised
Aquetia 25 mg/ml suspensie voor oraal gebruikSuspensie voor oraal gebruik	Quetiapine	Netherlands	Authorised	2025
BECAREN 1.000 MICROGRAMOS COMPRIMIDOS1.000 µg · Comprimido	Vitamin b12	Spain	Marketed	2025
BENLAXIDPolvere per soluzione orale	Macrogol	Italy	Authorised
BENLAXID 13,7 g poeder voor drankPoeder voor drank	Kaliumchloride, Macrogol, Cloreto	Netherlands	Authorised	2022
BENLAXID 6,9 g poeder voor drankPoeder voor drank	Kaliumchloride, Macrogol, Cloreto	Netherlands	Authorised	2022
BIMOTIL 13,7 G POLVO PARA SOLUCION ORAL13,125 g + 0,3507 g + 0,1785 g + 0,0466 g · Polvo para solución oral	Macrogol, Cloreto, Bicarbonate, Potassium	Spain	Marketed	2022
BIMOTIL INFANTIL 6,9 G POLVO PARA SOLUCION ORAL6,563 g + 0,1754 g + 0,0893 g + 0,0233 g · Polvo para solución oral	Macrogol, Cloreto, Bicarbonate, Potassium	Spain	Marketed	2022
Blissel 50 microgram/g, gel voor vaginaal gebruikGel voor vaginaal gebruik	Estriol	Netherlands	Authorised	2016
BLISSEL 50 microgramos/g GEL VAGINAL50 µg · Gel vaginal	Estriol	Spain	Marketed	2011
CADELIUS D 600 MG/1000 UI COMPRIMIDOS BUCODISPERSABLES0,025 mg + 1500 mg · Comprimido bucodispersable	Vitamin d, Carbonate	Spain	Marketed	2014
CADELIUS D 600 MG/2000 UI COMPRIMIDOS BUCODISPERSABLES1500 mg + 2000 UI · Comprimido bucodispersable	Carbonate, Vitamin d	Spain	Marketed	2020
CALCIPARINASoluzione iniettabile in siringa pre-riempita	Heparin	Italy	Authorised
CARIBAN 10 mg/10 mg CAPSULAS DURAS DE LIBERACION MODIFICADA10 mg + 10 mg · Cápsula dura de liberación modificada	Doxilamina, hidrogenosuccinato, Vitamin b6	Spain	Marketed	1967
CEFAZILPolvere e solvente per soluzione iniettabile	Cefazolin	Italy	Authorised
CLIVOTENCapsula rigida a rilascio prolungato	Isradipine	Italy	Authorised
COXUMADOL 500 mg/30 mg GRANULADO EFERVESCENTE500 mg + 30 mg · Granulado efervescente	Paracetamol, Codeine	Spain	Authorised	2004
DECORENONECapsula rigida	Ubidecarenone	Italy	Authorised
DEDRALENCompressa	Doxazosin	Italy	Authorised
DELTIUS 10.000 UI/ML GOTAS ORALES EN SOLUCION2,5 mg · Gotas orales en solución	Vitamin d	Spain	Marketed	2014
DELTIUS 25.000 UI/2,5 ML SOLUCION ORAL0,625 mg · Solución oral	Vitamin d	Spain	Marketed	2014
DELTIUS 25.000 UI CAPSULAS DURAS25000 ui · Cápsula dura	Vitamin d	Spain	Marketed	2019
DELTIUS 50.000 UI/2,5 ML SOLUCION ORAL50000 ui · Solución oral	Vitamin d	Spain	Marketed	2021
DELTIUS 50.000 UI CAPSULAS DURAS1,25 mg · Cápsula dura	Vitamin d	Spain	Marketed	2021

Know your medicines, with the sources.

One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.

Join Prognia free

Countries

Where it holds or makes medicines, with how many are current.

Country	Medicines	Current	Past	Companies
Spain	69	54	15	Companies All medicines
Italy	41	41	0	Companies All medicines
Netherlands	6	6	0	Companies All medicines
United States	2	2	0	Companies All medicines
European Union (EMA)	1	1	0	Companies All medicines

Also in the registers of Brazil, Croatia, France, Serbia, Singapore, United Kingdom

Sources and licences

Compiled by Prognia from the public medicine and company registers below. Logos are not used.

Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.

European Medicines Agency

Source: European Medicines Agency (EPAR data).

Licence: EMA reuse policy (source acknowledgement required)

Agencia Española de Medicamentos y Productos Sanitarios (CIMA)

Fuente de la información: AEMPS (CIMA).

Licence: AEMPS open data reuse with attribution

U.S. Food and Drug Administration (Drugs@FDA, openFDA)

Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.

Licence: Public domain (U.S. Government work)

Base de données publique des médicaments (ANSM, HAS, UNCAM)

Source: BDPM (ANSM, HAS, UNCAM).

Licence: Licence Ouverte v1.0

Anvisa, Brazil

Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.

Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required

All 22 sources

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required

BDPM / ANSM, HAS and UNCAM

BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained

Licence: BDPM exact Licence Ouverte v1.0 (October 2011)

Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom

Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.

Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom

Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.

Global Legal Entity Identifier Foundation

GLEIF; exact source URLs/locators, version status and retrieval dates. Normalized by Prognia; no official endorsement.

Licence: CC0

HALMED — Agencija za lijekove i medicinske proizvode RH

HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.

Licence: Otvorena dozvola RH

Agenzia Italiana del Farmaco (AIFA), Italy

Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/OFFICINE_API_GIUGNO_2025.csv; HTTP Last-Modified Tue, 08 Jul 2025 11:28:20 GMT; acquired 2026-10-13T17:21:05.497592+00:00; native fields retained, source identifier and role projections are adaptations.